» Articles » PMID: 26460989

Technology for Innovation in Radiation Oncology

Abstract

Radiation therapy is an effective, personalized cancer treatment that has benefited from technological advances associated with the growing ability to identify and target tumors with accuracy and precision. Given that these advances have played a central role in the success of radiation therapy as a major component of comprehensive cancer care, the American Society for Radiation Oncology (ASTRO), the American Association of Physicists in Medicine (AAPM), and the National Cancer Institute (NCI) sponsored a workshop entitled "Technology for Innovation in Radiation Oncology," which took place at the National Institutes of Health (NIH) in Bethesda, Maryland, on June 13 and 14, 2013. The purpose of this workshop was to discuss emerging technology for the field and to recognize areas for greater research investment. Expert clinicians and scientists discussed innovative technology in radiation oncology, in particular as to how these technologies are being developed and translated to clinical practice in the face of current and future challenges and opportunities. Technologies encompassed topics in functional imaging, treatment devices, nanotechnology, and information technology. The technical, quality, and safety performance of these technologies were also considered. A major theme of the workshop was the growing importance of innovation in the domain of process automation and oncology informatics. The technologically advanced nature of radiation therapy treatments predisposes radiation oncology research teams to take on informatics research initiatives. In addition, the discussion on technology development was balanced with a parallel conversation regarding the need for evidence of efficacy and effectiveness. The linkage between the need for evidence and the efforts in informatics research was clearly identified as synergistic.

Citing Articles

Analysis of Early Post-Radiation Surgical Management of Metastatic Spinal Tumors.

Seok S, Cho J, Lee H, Park J, Park J, Lee D J Clin Med. 2025; 14(3).

PMID: 39941700 PMC: 11818097. DOI: 10.3390/jcm14031032.


Clinical implications of the serum platelet-to-lymphocyte ratio in the modern radiation oncology era: research update and literature review.

Lee D Radiat Oncol. 2024; 19(1):107.

PMID: 39138484 PMC: 11323450. DOI: 10.1186/s13014-024-02485-8.


Twenty Years of Advancements in a Radiotherapy Facility: Clinical Protocols, Technology, and Management.

Tomatis S, Mancosu P, Reggiori G, Lobefalo F, Gallo P, Lambri N Curr Oncol. 2023; 30(7):7031-7042.

PMID: 37504370 PMC: 10378035. DOI: 10.3390/curroncol30070510.


The potential of ferroptosis combined with radiotherapy in cancer treatment.

Lu Z, Xiao B, Chen W, Tang T, Zhuo Q, Chen X Front Oncol. 2023; 13:1085581.

PMID: 37007068 PMC: 10064444. DOI: 10.3389/fonc.2023.1085581.


Evaluating patient reported outcomes and experiences in a novel proton beam clinic - challenges, activities, and outcomes of the ProtonCare project.

Sjovall K, Langegard U, Fransson P, Nevo-Ohlsson E, Kristensen I, Ahlberg K BMC Cancer. 2023; 23(1):132.

PMID: 36759789 PMC: 9909877. DOI: 10.1186/s12885-023-10586-y.


References
1.
Buckler A, Bresolin L, Reed Dunnick N, Sullivan D . A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging. Radiology. 2011; 258(3):906-14. DOI: 10.1148/radiol.10100799. View

2.
Lambin P, van Stiphout R, Starmans M, Rios-Velazquez E, Nalbantov G, Aerts H . Predicting outcomes in radiation oncology--multifactorial decision support systems. Nat Rev Clin Oncol. 2012; 10(1):27-40. PMC: 4555846. DOI: 10.1038/nrclinonc.2012.196. View

3.
OSullivan B, Huang S, Siu L, Waldron J, Zhao H, Perez-Ordonez B . Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol. 2013; 31(5):543-50. DOI: 10.1200/JCO.2012.44.0164. View

4.
Chatterjee D, Wolfe T, Lee J, Brown A, Singh P, Bhattarai S . Convergence of nanotechnology with radiation therapy-insights and implications for clinical translation. Transl Cancer Res. 2014; 2(4):256-268. PMC: 4179207. DOI: 10.3978/j.issn.2218-676X.2013.08.10. View

5.
Bradshaw T, Yip S, Jallow N, Forrest L, Jeraj R . Spatiotemporal stability of Cu-ATSM and FLT positron emission tomography distributions during radiation therapy. Int J Radiat Oncol Biol Phys. 2014; 89(2):399-405. PMC: 4041912. DOI: 10.1016/j.ijrobp.2014.02.016. View